According to filings with the U.S. Securities and Exchange Commission, RxAnte is raising $25,000,000.00 in new funding. Sources indicate as part of senior management Chief Operating Officer, Peter Aldrich played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About RxAnte
RxAnte is a leading predictive analytics and clinical services company dedicated to improving medication use and health outcomes. By providing health plans and providers with actionable insights, strategies, and a portfolio of interventions, RxAnte helps make medications work better for everyone. Created by experts in advanced analytics, medication adherence, health IT, and quality improvement, the RxAnte portfolio of solutions includes patented platforms that leverage predictive and decision analytics, advanced program evaluation methods, a web-based work flow solution, and an award-winning call center to provide clients with the insights they need and results they want in improving medication use.

To learn more about RxAnte, visit http://www.rxante.com/

Contact:
Peter Aldrich, Chief Operating Officer
207-619-9440
https://www.linkedin.com/in/peter-aldrich-2b0a4b8/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved